Eclosion SA: http://www.eclosion.ch/

Eclosion is a launching platform for new companies in the life sciences field. The company assists entrepreneurs with the necessary resources to cross the bridge between innovation and realistic venture. Eclosion is one of the co-founders of GeNeuro in March 2006. It has also offered GeNeuro a laboratory unit and the initial management support.

bioMérieux SA: http://www.biomerieux.com/

bioMérieux is a French company with global presence, specialized in the field of in vitro diagnostics for medical and industrial applications. bioMérieux is a co-founder of GeNeuro.

Mérieux Institute : http://www.institut-merieux.com

Mérieux Institute is a family holding company. This holding financially supports companies dedicated to the constant improvement of patient care quality and consumer health throughout the world through innovative biotechnology solutions. It manages a portfolio of 4 main financial investments, including bioMérieux SA, Transgène, ABL Inc and Siliker. Mérieux Institute invested in GeNeuro in 2008 to support the progress of the company.

New Investors:

GeNeuro is seeking to increase its capital to continue therapeutic development. The company is looking for new shareholders and venture capital risk investors.

For investor relations, please contact François Curtin.

contact@geneuro.com